Cyberonics Fails In Final Appeal For VNS Depression Medicare Coverage
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics was unsuccessful in a last-ditch effort to win Medicare coverage for its VNS Therapy System for treatment-resistant depression. HHS’ Departmental Appeals Board backed CMS’ 2007 decision that the depression indication is not reasonable and necessary.